SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 135 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,789,205 | +1567.5% | 192,094 | +2325.4% | 0.02% | +2000.0% |
Q1 2023 | $167,270 | -83.4% | 7,920 | -86.3% | 0.00% | -87.5% |
Q1 2022 | $1,005,000 | +22.1% | 57,804 | +53.7% | 0.01% | 0.0% |
Q4 2021 | $823,000 | +162.9% | 37,598 | +129.4% | 0.01% | +100.0% |
Q3 2021 | $313,000 | -13.8% | 16,393 | -22.6% | 0.00% | 0.0% |
Q2 2021 | $363,000 | -3.2% | 21,166 | +26.4% | 0.00% | -20.0% |
Q1 2021 | $375,000 | -51.0% | 16,751 | -51.4% | 0.01% | -54.5% |
Q4 2020 | $766,000 | +571.9% | 34,447 | +347.4% | 0.01% | +450.0% |
Q3 2020 | $114,000 | -50.2% | 7,700 | -50.2% | 0.00% | -50.0% |
Q2 2020 | $229,000 | +1247.1% | 15,461 | +621.1% | 0.00% | +300.0% |
Q3 2018 | $17,000 | +6.2% | 2,144 | +78.7% | 0.00% | 0.0% |
Q1 2017 | $16,000 | -15.8% | 1,200 | -55.0% | 0.00% | -50.0% |
Q4 2016 | $19,000 | – | 2,666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |